Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Rezolute, Inc. stock logo
RZLT
Rezolute
$3.92
-6.7%
$4.04
$1.07
▼
$11.16
$346.29M0.651.61 million shs2.47 million shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Rezolute, Inc. stock logo
RZLT
Rezolute
-6.67%+7.40%+5.95%-22.99%-61.42%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Rezolute, Inc. stock logo
RZLT
Rezolute
$3.92
-6.7%
$4.04
$1.07
▼
$11.16
$346.29M0.651.61 million shs2.47 million shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Rezolute, Inc. stock logo
RZLT
Rezolute
-6.67%+7.40%+5.95%-22.99%-61.42%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Rezolute, Inc. stock logo
RZLT
Rezolute
2.79
Moderate Buy$11.67197.62% Upside

Current Analyst Ratings Breakdown

Latest RZLT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/18/2026
Rezolute, Inc. stock logo
RZLT
Rezolute
UpgradeStrong Sell ➝ Hold
11/17/2026
Rezolute, Inc. stock logo
RZLT
Rezolute
Boost Price TargetOutperform$6.00 ➝ $10.00
10/15/2026
Rezolute, Inc. stock logo
RZLT
Rezolute
Reiterated RatingSell (D-)
10/15/2026
Rezolute, Inc. stock logo
RZLT
Rezolute
Reiterated RatingMarket Outperform
10/13/2026
Rezolute, Inc. stock logo
RZLT
Rezolute
DowngradeHold ➝ Strong Sell
10/6/2026
Rezolute, Inc. stock logo
RZLT
Rezolute
Boost Price TargetBuy$9.00 ➝ $12.00
10/6/2026
Rezolute, Inc. stock logo
RZLT
Rezolute
Reiterated RatingOutperform
10/6/2026
Rezolute, Inc. stock logo
RZLT
Rezolute
Boost Price TargetMarket Outperform$11.00 ➝ $15.00
10/5/2026
Rezolute, Inc. stock logo
RZLT
Rezolute
UpgradeNeutral ➝ Overweight
9/30/2026
Rezolute, Inc. stock logo
RZLT
Rezolute
Initiated CoverageBuy$9.00
(Data available from 11/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Rezolute, Inc. stock logo
RZLT
Rezolute
N/AN/AN/AN/A$0.89 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Rezolute, Inc. stock logo
RZLT
Rezolute
-$77.59M-$0.76N/AN/AN/AN/A-72.24%-65.90%N/A

Latest RZLT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q1 2027
Rezolute, Inc. stock logo
RZLT
Rezolute
-$0.1854-$0.18+$0.0054-$0.18$1.12 millionN/A
9/24/2026Q4 2026
Rezolute, Inc. stock logo
RZLT
Rezolute
-$0.1479-$0.20-$0.0522-$0.20N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Rezolute, Inc. stock logo
RZLT
Rezolute
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Rezolute, Inc. stock logo
RZLT
Rezolute
N/A
9.92
9.92

Institutional Ownership

CompanyInstitutional Ownership
Rezolute, Inc. stock logo
RZLT
Rezolute
82.97%

Insider Ownership

CompanyInsider Ownership
Rezolute, Inc. stock logo
RZLT
Rezolute
15.05%
CompanyEmployeesShares OutstandingFree FloatOptionable
Rezolute, Inc. stock logo
RZLT
Rezolute
5896.73 million82.17 millionOptionable

Recent News About These Companies

Zacks Research Upgrades Rezolute (NASDAQ:RZLT) to "Hold"
Rezolute (NASDAQ:RZLT) Stock Price Expected to Rise, Wedbush Analyst Says
Rezolute stock rises on positive Phase 3 upLIFT trial results
HC Wainwright Brokers Reduce Earnings Estimates for Rezolute

New MarketBeat Followers Over Time

Media Sentiment Over Time

Rezolute stock logo

Rezolute NASDAQ:RZLT

$3.92 -0.28 (-6.67%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$3.99 +0.07 (+1.79%)
As of 11/20/2026 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Rezolute, Inc., a clinical stage biopharmaceutical company, develops therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, an oral plasma kallikrein inhibitor, which is in clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.